| Preface |
|
ix | |
|
Section 1 Access for Hemodialysis |
|
|
|
Chapter 1 The Hemodialysis Arteriovenous Fistula |
|
|
1 | (12) |
|
|
|
|
|
Chapter 2 Central Venous Catheters and Outcomes in Hemodialysis |
|
|
13 | (12) |
|
|
|
Section 2 Modelling and Dialysis |
|
|
|
Chapter 3 Basic Principles and Modeling of Dialysis |
|
|
25 | (16) |
|
|
|
Chapter 4 Membranes for Haemodialysis: What Do We Have, What Do We Need? |
|
|
41 | (10) |
|
|
|
Chapter 5 Undesirable Substances in Water Hemodialysis |
|
|
51 | (16) |
|
|
|
Chapter 6 The Exchangeable Calcium Pool: From Physiology to Pathophysiology in Chronic Kidney Disease |
|
|
67 | (12) |
|
|
|
|
|
Section 3 Timing of Dialysis |
|
|
|
Chapter 7 Timing of Dialysis Initiation |
|
|
79 | (6) |
|
|
|
Chapter 8 An Empirical Approach to Incremental Hemodialysis |
|
|
85 | (16) |
|
|
|
Chapter 9 In Eldery Patients with ESRD: Opt for Dialysis, Diet Treatment, or No Dialysis? |
|
|
101 | (10) |
|
|
|
Section 4 Hemodialysis and Infection |
|
|
|
Chapter 10 De Novo Hepatitis B Virus Infection in a Mayo Clinic Hemodialysis Population, 2000-2010: Practical Lessons - the Economic Impact of Reduced HBV Testing and a Call for Paradigm Changes in Current US CDC Guidelines on HBV Testing Protocols |
|
|
111 | (20) |
|
|
|
|
|
Chapter 11 Tuberculosis in Hemodialysis |
|
|
131 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Section 5 Hemodialysis in Extra-Renal Disease |
|
|
|
Chapter 12 Low Density Lipoprotein Apheresis |
|
|
145 | (12) |
|
|
|
|
|
Chapter 13 Immunoadsorption for Treatment of Antibody-Mediated Diseases |
|
|
157 | (24) |
|
|
|
Section 6 Alternative Hemodialysis Techniques |
|
|
|
Chapter 14 Nocturnal Hemodialysis: Pros and Cons |
|
|
181 | (20) |
|
|
|
|
|
Chapter 15 Daily Dialysis and Outcomes in ESRD Patients Lucia Di Micco, Francesco Mirenghi, Serena Torraca, Maria Luisa Sirico, Luigi Russo and Biagio Raffaele Di Iorio |
|
|
201 | (12) |
|
Chapter 16 Renal Replacement Therapy in the Intensive Care Unit: The Case of Sustained Low-Efficiency Dialysis |
|
|
213 | (6) |
|
|
|
|
|
Chapter 17 The Role of Dialysis in the Prevention of Contrast-Induced Nephropathy |
|
|
219 | (10) |
|
|
|
|
|
Chapter 18 Continuous Flow Peritoneal Dialysis: Update 2012 |
|
|
229 | (14) |
|
|
|
|
|
|
|
Chapter 19 Wearable Artificial Kidney |
|
|
243 | (18) |
|
|
|
|
|
|
|
|
|
|
|
Section 7 Convective Treatments |
|
|
|
Chapter 20 Principles of Backfiltration and Selection of Dialysis Techniques |
|
|
261 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chapter 21 High-Efficiency Hemodiafiltration for All: Changing Paradigms of Renal Replacement Therapy for Improving Global Outcomes of Chronic Kidney Disease Stage 5 Dialysis Patients |
|
|
277 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chapter 22 Hemodiafiltration with Endogenous Reinfusion (HFR) |
|
|
293 | (18) |
|
|
|
|
|
Chapter 23 Acetate-Free Biofiltration |
|
|
311 | (12) |
|
|
|
|
|
|
|
Chapter 24 Hemodiafiltration in Patients with Complication of Long-Term Dialysis Hideki Kawanishi |
|
|
323 | (18) |
|
Section 8 Clinical Aspects in Hemodialysis |
|
|
|
Chapter 25 Protein-Energy Malnutrition in Dialysis Patients and Morbidity/Mortality Consequence |
|
|
341 | (12) |
|
|
|
Chapter 26 The Phenomenon of Hemoglobin Variability in Chronic Kidney Disease |
|
|
353 | (12) |
|
|
|
|
|
|
|
|
|
Chapter 27 Electrotherapy in End-Stage Renal Disease: Potential Indications in Pain and Muscle Wasting |
|
|
365 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Chapter 28 Ankle-Brachial Index Is Associated with Vascular Calcifications and Cardiovascular Risk in Dialysis Patients |
|
|
377 | (12) |
|
|
|
Chapter 29 Hyperphosphatemia and Cardiotoxicity: Association or Causality? |
|
|
389 | (24) |
|
|
|
|
|
|
|
Chapter 30 Inflammation, Arterial Stiffness and Cardiovascular Events in Hemodialysis |
|
|
413 | (14) |
|
|
|
Chapter 31 Sleep Disorders in Renal Disease |
|
|
427 | (16) |
|
|
|
|
|
Chapter 32 The Syndrome of Rapid Onset End-Stage Renal Disease (SORO-ESRD) - A New Mayo Clinic Dialysis Services Experience, January 2010-February 2011 |
|
|
443 | (44) |
|
|
|
|
|
Chapter 33 Effect of Uremic Toxins on Drug Pharmacokinetics in Renal Failure |
|
|
487 | (14) |
|
|
|
|
|
Chapter 34 Erythropoietin and Tissue Protection |
|
|
501 | (18) |
|
|
|
|
|
Chapter 35 Fatigue in Patients on Chronic Hemodialysis: Prevalence, Pathogenesis and Therapy |
|
|
519 | (12) |
|
|
|
|
|
Chapter 36 Clinical Outcomes of Metabolic Acidosis in ESRD |
|
|
531 | (18) |
|
|
|
|
|
Chapter 37 Palliative Care in Chronic Kidney Disease |
|
|
549 | (28) |
|
|
|
|
| About the Editors |
|
577 | (6) |
| Index |
|
583 | |
